The Official MicroCap News Source
Watchlist News
Please Login or Register to view News Stories

Update with MabVax Therapeutics Holdings, Inc. - Antibody-based Products Company Discusses Clinical Developments, Goals and Milestones for 2016

In this SNNLive In-Studio Video Interview, our host caught up with David Hansen, President and CEO of MabVax Therapeutics Holdings, Inc. (NASDAQ: MBVX), on August 22nd, 2016 from our studio in Los Angeles, CA.

Share With

Wednesday, September 07, 2016

   

© 2017 Stock News Now